My watch list
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
My watch list
My saved searches
My saved topics
Public NYSE: ENDP Founded Headquarters Chadds Ford, Pennsylvania Industry Pharmaceuticals
Endo Pharmaceuticals Inc. as a result of a management buyout from DuPont Merck in 1997. Endo is a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.
Chief financial officer: Charles A. Rowland Jr. (as of December 2006, replacing Jeff Black)
 The company's sales force numbers 590
Carbidopa with levodopa (Carbidopa/Levodopa USP)
Hydrocodone with acetominophen (Zydone®)
Hydrocodone with homatropine (Hycodan®)
Lidocaine with tetracaine (Synera®)
Oxycodone with acetominophen (Percocet®, Endocet®)
Oxycodone with aspirin (Percodan®)
a Staff. "Endo Pharmaceuticals names new CFO", Delaware News Journal, December 6, 2006. Retrieved on 2006-12-06. b
Product Listing. Endo Pharmaceuticals (2006). Retrieved on 2006-12-06.
This article is licensed under the
GNU Free Documentation License. It uses material from the Wikipedia article "Endo_Pharmaceuticals". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE